Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome

Al-Sarraj, 2011, p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS., Acta Neuropathol., 122, 691, 10.1007/s00401-011-0911-2

Atwood, 2011, Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis., BMC Genomics, 12, 10.1186/1471-2164-12-14

Basu, 2011, Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease., Immunol. Res., 51, 26, 10.1007/s12026-011-8210-5

Brinks, 2010, Regulation of GPCR signaling in hypertension., Biochim. Biophys Acta, 1802, 1268, 10.1016/j.bbadis.2010.01.005

Cabral, , Endocannabinoids and the immune system in health and disease., Handb. Exp. Pharmacol., 231, 185, 10.1007/978-3-319-20825-1_6

Cabral, , Turning over a new leaf: cannabinoid and endocannabinoid modulation of immune function., J. Neuroimmune Pharmacol., 10, 193, 10.1007/s11481-015-9615-z

Cassano, 2017, Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target., Front. Neurosci., 11, 10.3389/fnins.2017.00030

Cavey, 2006, Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget’s disease of bone., Calcif. Tissue Int., 78, 271, 10.1007/s00223-005-1299-6

Cecyre, 2014, Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina., Naunyn Schmiedebergs Arch. Pharmacol., 387, 175, 10.1007/s00210-013-0930-8

Cha-Molstad, 2015, Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding., Nat. Cell Biol., 17, 917, 10.1038/ncb3177

Chapple, 2003, The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation., J. Biol. Chem., 278, 19087, 10.1074/jbc.m212349200

Cheshenko, 2018, Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry., PLoS Pathog., 14, 10.1371/journal.ppat.1006766

Cohen-Kaplan, 2016, p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome., Proc. Natl. Acad. Sci. U.S.A., 113, E7490, 10.1073/pnas.1615455113

Contino, 2017, Editorial: the CB2 cannabinoid system: a new strategy in neurodegenerative disorder and neuroinflammation., Front. Neurosci., 11, 10.3389/fnins.2017.00196

Daulat, 2009, Recent methodological advances in the discovery of GPCR-associated protein complexes., Trends Pharmacol. Sci., 30, 72, 10.1016/j.tips.2008.10.009

Dhopeshwarkar, 2014, CB2 cannabinoid receptors as a therapeutic target-what does the future hold?, Mol. Pharmacol., 86, 430, 10.1124/mol.114.094649

Duran, 2016, p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer., Cancer Cell, 30, 595, 10.1016/j.ccell.2016.09.004

Duvernay, 2011, Alpha2B-adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface., J. Biol. Chem., 286, 14080, 10.1074/jbc.M111.222323

Fecto, 2011, SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis., Arch. Neurol., 68, 1440, 10.1001/archneurol.2011.250

Festjens, 2007, RIP1, a kinase on the crossroads of a cell’s decision to live or die., Cell Death Differ., 14, 400, 10.1038/sj.cdd.4402085

Finlay, 2017, Galphas signalling of the CB1 receptor and the influence of receptor number., Br. J. Pharmacol., 174, 2545, 10.1111/bph.13866

Fujita, 2011, Nrf2-mediated induction of p62 controls toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation., Proc. Natl. Acad. Sci. U.S.A., 108, 1427, 10.1073/pnas.1014156108

Gandia, 2013, The Parkinson’s disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain., J. Neurochem., 125, 362, 10.1111/jnc.12196

Glatter, 2009, An integrated workflow for charting the human interaction proteome: insights into the PP2A system., Mol. Syst. Biol., 5, 10.1038/msb.2008.75

Guida, 2017, Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor., Sci. Rep., 7, 10.1038/s41598-017-00342-1

Guindon, 2008, Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain., Br. J. Pharmacol., 153, 319, 10.1038/sj.bjp.0707531

Heng, 2013, An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases., Biotechnol. Adv., 31, 1676, 10.1016/j.biotechadv.2013.08.017

Hua, 2016, Crystal structure of the human cannabinoid receptor CB1., Cell, 167, 750.e14, 10.1016/j.cell.2016.10.004

Huang da, , Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists., Nucleic Acids Res., 37, 1, 10.1093/nar/gkn923

Huang da, , Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources., Nat. Protoc., 4, 44, 10.1038/nprot.2008.211

Hunter, 2017, Real-time measurement of cannabinoid receptor-mediated cAMP signaling., Methods Enzymol., 593, 43, 10.1016/bs.mie.2017.05.001

Katsuragi, 2015, p62/SQSTM1 functions as a signaling hub and an autophagy adaptor., FEBS J., 282, 4672, 10.1111/febs.13540

Kim, 2009, The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity., J. Immunol., 182, 2131, 10.4049/jimmunol.0802755

Kittanakom, 2014, CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human beta(2)-adrenergic receptor., Biochem. Biophys. Res. Commun., 445, 746, 10.1016/j.bbrc.2014.02.033

Komatsu, 2007, Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice., Cell, 131, 1149, 10.1016/j.cell.2007.10.035

Krishna Kumar, 2019, Structure of a signaling cannabinoid receptor 1-G protein complex., Cell, 176, 448.e12, 10.1016/j.cell.2018.11.040

Kwon, 2018, Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter., Nat. Commun., 9, 10.1038/s41467-018-05825-x

Lappano, 2011, G protein-coupled receptors: novel targets for drug discovery in cancer., Nat. Rev. Drug Discov., 10, 47, 10.1038/nrd3320

Laurin, 2002, Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in paget disease of bone., Am. J. Hum. Genet., 70, 1582, 10.1086/340731

Li, 2019, Crystal structure of the human cannabinoid receptor CB2., Cell, 176, 459.e13, 10.1016/j.cell.2018.12.011

Lin, 2013, Interaction domains of p62: a bridge between p62 and selective autophagy., DNA Cell Biol., 32, 220, 10.1089/dna.2012.1915

Lunn, 2008, Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists., Br. J. Pharmacol., 153, 226, 10.1038/sj.bjp.0707480

Luo, 2011, Proteinase-activated receptors, nucleotide P2Y receptors, and mu-opioid receptor-1B are under the control of the type I transmembrane proteins p23 and p24A in post-Golgi trafficking., J. Neurochem., 117, 71, 10.1111/j.1471-4159.2011.07173.x

Mallat, 2013, Cannabinoid signaling and liver therapeutics., J. Hepatol., 59, 891, 10.1016/j.jhep.2013.03.032

Mattheus, 2016, Cell Type-specific tandem affinity purification of the mouse hippocampal CB1 receptor-associated proteome., J. Proteome Res., 15, 3585, 10.1021/acs.jproteome.6b00339

Moscat, 2011, Feedback on fat: p62-mTORC1-autophagy connections., Cell, 147, 724, 10.1016/j.cell.2011.10.021

Moscat, 2007, Signal integration and diversification through the p62 scaffold protein., Trends Biochem. Sci., 32, 95, 10.1016/j.tibs.2006.12.002

Mukhopadhyay, 2000, The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain., Mol. Pharmacol., 57, 162

Nagler, 2016, Cannabinoid receptor 2 expression modulates Gbeta(1)gamma(2) protein interaction with the activator of G protein signalling 2/dynein light chain protein Tctex-1., Biochem. Pharmacol., 99, 60, 10.1016/j.bcp.2015.09.017

O’Gorman, 1991, Recombinase-mediated gene activation and site-specific integration in mammalian cells., Science, 251, 1351, 10.1126/science.1900642

Pacher, 2011, Is lipid signaling through cannabinoid 2 receptors part of a protective system?, Prog. Lipid Res., 50, 193, 10.1016/j.plipres.2011.01.001

Pankiv, 2007, p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy., J. Biol. Chem., 282, 24131, 10.1074/jbc.m702824200

Pertwee, 2012, Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities., Philos. Trans. R. Soc. Lond. B Biol. Sci., 367, 3353, 10.1098/rstb.2011.0381

Pinna, 2005, New therapies for the treatment of Parkinson’s disease: adenosine A2A receptor antagonists., Life Sci., 77, 3259, 10.1016/j.lfs.2005.04.029

Racz, , Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain., J. Neurosci., 28, 12125, 10.1523/JNEUROSCI.3400-08.2008

Racz, , Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain., J. Neurosci., 28, 12136, 10.1523/JNEUROSCI.3402-08.2008

Rosenbaum, 2006, Calnexin is essential for rhodopsin maturation, Ca2+ regulation, and photoreceptor cell survival., Neuron, 49, 229, 10.1016/j.neuron.2005.12.011

Sanchez-Martin, 2018, p62/SQSTM1 - steering the cell through health and disease., J. Cell Sci., 131, 10.1242/jcs.222836

Sanz, 1999, The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation., EMBO J., 18, 3044, 10.1093/emboj/18.11.3044

Seilhean, 2009, Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation., Acta Neuropathol., 118, 561, 10.1007/s00401-009-0545-9

Seitz, 2008, The second most common bone disease: a review on Paget’s disease of bone., Eur. J. Trauma Emerg. Surg., 34, 549, 10.1007/s00068-008-8208-4

Sokolina, 2017, Systematic protein-protein interaction mapping for clinically relevant human GPCRs., Mol. Syst. Biol., 13, 10.15252/msb.20167430

Steffens, 2005, Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice., Nature, 434, 782, 10.1038/nature03389

Szklarczyk, 2015, STRING v10: protein-protein interaction networks, integrated over the tree of life., Nucleic Acids Res., 43, D447, 10.1093/nar/gku1003

Toguri, 2014, Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis., Br. J. Pharmacol., 171, 1448, 10.1111/bph.12545

Tuusa, 2010, Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin., FEBS J., 277, 2815, 10.1111/j.1742-4658.2010.07699.x

Williams, 2014, Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection., J. Neuroimmune Pharmacol., 9, 369, 10.1007/s11481-014-9527-3

Wright, 1984, Structural comparison of the two distinct sugar binding sites in wheat germ agglutinin isolectin II., J. Mol. Biol., 178, 91, 10.1016/0022-2836(84)90232-8

Xiang, 2018, Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression., Nat. Commun., 9, 10.1038/s41467-018-04999-8